NCT06109805Completed
Plasma Metabolic Biomarkers for Gastric Cancer Diagnosis
Identification and Multicentral Clinical Validation of Plasma Diagnostic Biomarkers for Gastric Cancer Based on Wide-targeted and Targeted Metabolomics
Source: ClinicalTrials.gov · Last updated 20 Feb 2025
Brief summary (registry, in English)
The aim of this observational study is to comprehensively analyze the metabolites in plasma samples from gastric cancer patients using advanced mass spectrometry detection technology, in conjunction with both broad-spectrum and targeted metabolomics approaches. The goal is to construct a dedicated plasma metabolite database for gastric cancer patients. Simultaneously, we will delve into the exploration and validation of a series of metabolic biomarkers for early gastric cancer diagnosis. The objective is to establish a safer, more convenient, and more sensitive early screening method, thereby providing a reliable scientific foundation and critical evidence for improving the early diagnostic process for individuals at high risk of gastric cancer.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1706 (actual)
- First submitted
- 26 Oct 2023
- Start date
- 20 Oct 2023
- Primary completion date
- 18 Feb 2025
- Lead sponsor
- Beijing Friendship Hospital
- NCT number
- NCT06109805
What you commit to
- Study type: Observational
- Participants enrolled: 1706
- From 20 Oct 2023 to the primary completion date, 18 Feb 2025
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous reception of anti-tumor treatments (including radiotherapy, chemotherapy, etc.) before blood collection.
- Absence of plasma sample collection before surgical treatment.
Other
- Coexistence of other systemic tumors.
- Incomplete clinical data.
- Pregnancy status.
Who the study is looking for
- Confirmed diagnosis of gastric cancer or benign gastric diseases through gastroscopy and pathological examination.
- Collection of plasma samples prior to surgical treatment.
- Availability of complete clinical data.
Sex: All · Accepts healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cancer Hospital, Chinese Academy of Medical Sciences Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
| Beijing Friendship Hospital, Capital Medical University Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
| Renmin Hospital of Wuhan University Coordinator of this site? Confirm its status | Wuhan | China | Unknown status |
| Tongji Hospital Tongji Medical College of Hust Coordinator of this site? Confirm its status | Wuhan | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.